Review paper
Interleukin-1 Beta as a Target for Atherosclerosis Therapy
Volume: 70, Issue: 18, Pages: 2278 - 2289
Published: Oct 1, 2017
Abstract
Inflammatory pathways drive atherogenesis and link conventional risk factors to atherosclerosis and its complications. One inflammatory mediator has come to the fore as a therapeutic target in cardiovascular disease. The experimental and clinical evidence reviewed here support interleukin-1 beta (IL-1β) as both a local vascular and systemic contributor in this regard. Intrinsic vascular wall cells and lesional leukocytes alike can produce this...
Paper Details
Title
Interleukin-1 Beta as a Target for Atherosclerosis Therapy
Published Date
Oct 1, 2017
Volume
70
Issue
18
Pages
2278 - 2289
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History